2010
HIV Disclosure, Condom Use, and Awareness of HIV Infection Among HIV-Positive, Heterosexual Drug Injectors in St. Petersburg, Russian Federation
Grau LE, White E, Niccolai LM, Toussova OV, Verevochkin SV, Kozlov AP, Heimer R. HIV Disclosure, Condom Use, and Awareness of HIV Infection Among HIV-Positive, Heterosexual Drug Injectors in St. Petersburg, Russian Federation. AIDS And Behavior 2010, 15: 45-57. PMID: 20700645, PMCID: PMC3023022, DOI: 10.1007/s10461-010-9775-z.Peer-Reviewed Original Research
2008
High HIV Prevalence, Suboptimal HIV Testing, and Low Knowledge of HIV-Positive Serostatus Among Injection Drug Users in St. Petersburg, Russia
Niccolai LM, Toussova OV, Verevochkin SV, Barbour R, Heimer R, Kozlov AP. High HIV Prevalence, Suboptimal HIV Testing, and Low Knowledge of HIV-Positive Serostatus Among Injection Drug Users in St. Petersburg, Russia. AIDS And Behavior 2008, 14: 932-941. PMID: 18843531, PMCID: PMC3116648, DOI: 10.1007/s10461-008-9469-y.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV-positive serostatusHIV prevalenceHIV testingDrug usersHuman immunodeficiency virus (HIV) prevalenceRecent doctor visitHigh HIV prevalenceUnsafe injectionsPositive serostatusDoctor visitsSerostatusHIVPrevalencePoor knowledgeVirus prevalenceLow knowledgeTesting patternsHistory/Adequate coverageCorrelatesInfectionVisitsMonths
2001
Can HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users.
Abdala N, Gleghorn A, Carney J, Heimer R. Can HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 487. PMID: 11744839, DOI: 10.1097/00042560-200112150-00013.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV-1Undiluted bleachDrug usersHIV-1 recoveryViable HIV-1HIV-1 transmissionHarm reduction interventionsEffectiveness of bleachNeedle exchangeReduction interventionsMicroculture assaySingle rinseSterile syringeSyringesInjection behaviorEducational programsMinimal contact timeDevelopment and Application of a Genotypic AZT Resistance Assay: Quantitative Assessment of the Resistance Profile of Clinical Samples and the Relative Predictive Ability of a Resistance Index.
Kyriakides TC, Heimer RR. Development and Application of a Genotypic AZT Resistance Assay: Quantitative Assessment of the Resistance Profile of Clinical Samples and the Relative Predictive Ability of a Resistance Index. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 211. PMID: 11694826, DOI: 10.1097/00042560-200111010-00002.Peer-Reviewed Original ResearchConceptsViral loadCD4 countResistance indexAZT resistanceResistance profilesBaseline viral loadHIV disease progressionLigase chain reaction assayMonths of treatmentWild-type HIV-1Resistance assaysAntiretroviral therapyDisease progressionSurrogate markerChain reaction assaysHIV-1PatientsAZTPredictive abilityClinical samplesReaction assaysCountAssaysRelative predictive abilityFurther support
2000
Viability of HIV-1 in syringes: implications for interventions among injection drug users.
Heimer R, Abdala N. Viability of HIV-1 in syringes: implications for interventions among injection drug users. The AIDS Reader 2000, 10: 410-7. PMID: 10932845.Peer-Reviewed Original ResearchSurvival of HIV-1 in Syringes: Effects of Temperature during Storage
Abdala N, Reyes R, Carney J, Heimer R. Survival of HIV-1 in Syringes: Effects of Temperature during Storage. Substance Use & Misuse 2000, 35: 1369-1383. PMID: 10921429, DOI: 10.3109/10826080009148220.Peer-Reviewed Original Research
1999
HIV-1 Transmission in Injection Paraphernalia: Heating Drug Solutions May Inactivate HIV-1
Clatts M, Heimer R, Abdala N, Goldsamt L, Sotheran J, Anderson K, Gallo T, Hoffer L, Luciano P, Kyriakides T. HIV-1 Transmission in Injection Paraphernalia: Heating Drug Solutions May Inactivate HIV-1. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 22: 194-199. PMID: 10843535, DOI: 10.1097/00126334-199910010-00013.Peer-Reviewed Original ResearchSurvival of HIV-1 in Syringes
Abdala N, Stephens C, Griffith B, Heimer R. Survival of HIV-1 in Syringes. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 20: 73-80. PMID: 9928733, DOI: 10.1097/00042560-199901010-00011.Peer-Reviewed Original Research
1998
Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection
Rich J, Dickinson B, Carney J, Fisher A, Heimer R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS 1998, 12: 2345-2350. PMID: 9863878, DOI: 10.1097/00002030-199817000-00017.Peer-Reviewed Original Research
1995
HIV Incidence Among New Haven Needle Exchange Participants
Kaplan E, Heimer R. HIV Incidence Among New Haven Needle Exchange Participants. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 10: 175-176. PMID: 7552482, DOI: 10.1097/00042560-199510020-00010.Peer-Reviewed Original Research
1993
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut
Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.Peer-Reviewed Original ResearchConceptsHIV-1 proviral DNANeedle exchange programsProviral DNANew Haven's needle exchange programNeedle exchangeHIV-1 prevalenceIntravenous drug usersNeedle exchange clientsDrug treatment programsPercentage of syringesDrug use habitsSyringe trackingDNA prevalenceNew HavenPolymerase chain reactionDrug treatmentDrug usersTreatment programPrevalenceChain reactionExchange programsSyringesMonthsProgram participantsFunded evaluationHIV DNA and antibodies in syringes from injecting drug users, a comparison of detection techniques
Myers S, Heimer R, Liu D, Henrard D. HIV DNA and antibodies in syringes from injecting drug users, a comparison of detection techniques. AIDS 1993, 7: 925-932. PMID: 8357554, DOI: 10.1097/00002030-199307000-00004.Peer-Reviewed Original Research
1992
Prevalence of HIV-Infected Syringes during a Syringe-Exchange Program
Heimer R, Kaplan E, Cadman E. Prevalence of HIV-Infected Syringes during a Syringe-Exchange Program. New England Journal Of Medicine 1992, 327: 1883-1884. PMID: 1448131, DOI: 10.1056/nejm199212243272613.Peer-Reviewed Original Research